Effects of gold sodium thiomalate on interferon stimulation of C2 synthesis and HLA–DR expression by human monocytes

Abstract

Gamma-interferon (γ-IFN) is a T cell–derived lymphokine that has potent macrophage-activating properties. It increases Fc receptor density, increases the formation and release of reactive oxygen intermediates, increases the synthesis and release of complement cascade proteins, especially C2 and factor B, and increases class II (HLA–DR) antigen expression. These effects may play a role in the potentiation of inflammation in rheumatoid arthritis. We examined the possibility that gold sodium thiomalate (GST), an effective treatment for rheumatoid arthritis, would inhibit γ-IFN–mediated stimulation of monocyte/macrophages. GST in concentrations attainable in vivo was shown to inhibit both spontaneous and γ-IFN–stimulated C2 production up to 50%. GST inhibition could be only partially overcome with increasing concentrations of γ-IFN. In addition, GST inhibited γ-IFN–stimulated HLA-DR expression at the highest concentrations tested (20–50 μg/ml). GST alone in low concentrations (0.1–5 μg/ml) was found to increase HLA-DR antigen expression as quantitated by several methods, including flow cytometry, cell surface enzyme-linked immunosorbent assay, and Western blotting. This GST-stimulated increase in HLA-DR antigen expression paralleled an increased ability of monocytes to present antigen. The mechanism by which low concentrations of GST stimulate HLA-DR antigen expression is unclear, but was shown by ³⁵S-methionine cell labeling not to involve increased HLA-DR protein synthesis.